{"id":"tis-u-sol","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3919361","moleculeType":"Small molecule","molecularWeight":"516.65"},"_dailymed":{"setId":"9da4121f-d62d-4da4-8dfb-0494da16015f","title":"TIS-U-SOL (SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE) IRRIGANT [BAXTER HEALTHCARE CORPORATION]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tis-U-Sol appears to be a formulation or delivery technology platform rather than a traditional small-molecule or biologic drug. It is developed by an oncology-focused institution and likely functions as an adjunctive or enabling technology to improve therapeutic agent distribution to tumor tissues or other target sites. Specific mechanistic details regarding its molecular targets or active components are not publicly well-characterized.","oneSentence":"Tis-U-Sol is a tissue-specific drug delivery system designed to enhance drug penetration and retention in target tissues.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T04:05:41.661Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cancer (specific indication not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT04870905","phase":"PHASE2","title":"Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","startDate":"2023-03-01","conditions":"Nasopharyngeal Neoplasms","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"19940930","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19911114","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19890726","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19850626","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19840228","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"20110928","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19850124","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"20150203","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19930914","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19910326","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19900518","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19861030","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"20150626","type":"SUPPL","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"},{"date":"19820219","type":"ORIG","sponsor":"BAXTER HLTHCARE","applicationNumber":"NDA018508"}],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Tis-U-Sol","genericName":"Tis-U-Sol","companyName":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","companyId":"affiliated-cancer-hospital-institute-of-guangzhou-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tis-U-Sol is a tissue-specific drug delivery system designed to enhance drug penetration and retention in target tissues. Used for Cancer (specific indication not publicly detailed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}